We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquapl... Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. Show more
Continued progress of pivotal Phase 3 study (TransportNPC™) evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) toward 48-week comparative interim analysis data...
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and...
Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1 | 8.33333333333 | 1.2 | 1.32 | 1.1 | 45046 | 1.22301041 | CS |
4 | -0.08 | -5.79710144928 | 1.38 | 1.79 | 1.1 | 105129 | 1.39060824 | CS |
12 | -0.6 | -31.5789473684 | 1.9 | 1.92 | 1.1 | 96836 | 1.53667728 | CS |
26 | 0.29 | 28.7128712871 | 1.01 | 2.115 | 0.8924 | 101935 | 1.55811409 | CS |
52 | 0.4664 | 55.9500959693 | 0.8336 | 2.57 | 0.6801 | 97818 | 1.51252218 | CS |
156 | -5.82 | -81.7415730337 | 7.12 | 13 | 0.67 | 101506 | 4.36775658 | CS |
260 | -3.05 | -70.1149425287 | 4.35 | 17.75 | 0.67 | 228325 | 6.38285113 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions